Oliver Waidmann
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: July 15, 2025
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.
Journal: Biochemical and biophysical research communications
Published: May 24, 2024
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).
Journal: Journal of cancer research and clinical oncology
Published: April 02, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: March 17, 2024
Last Updated: 09/26/2026